Latest Carpuject Stories
YORK, Pa., Aug. 9, 2011 /PRNewswire/ -- Unilife Corporation ("Unilife" or the "Company") (NASDAQ: UNIS; ASX: UNS) today announced that Mr. Jim Bosnjak OAM, Chairman of Unilife, issued an open letter to shareholders as an update on the Company's business. Dear Shareholder, As you may be aware, the global economy has taken a significant step backwards in the last few weeks due to uncertainty and instability across international markets, including the Middle East, the Japanese tsunami, and...
PISCATAWAY, N.J., Aug. 8, 2011 /PRNewswire/ -- INNOPHARMA LLC announced today FDA approval of its Abbreviated New Drug Application (ANDA) for levetiracetam injection (the generic equivalent of Keppra® injection from UCB Inc). As the developer of this generic injectable drug, INNOPHARMA entered into a license agreement with X-GEN Pharmaceuticals, Inc. for marketing and product distribution in the US. About INNOPHARMA: INNOPHARMA is a sterile product development company, focused on...
LAKE FOREST, Ill., Aug. 5, 2011 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world leader in generic injectable pharmaceuticals, today announced U.S. Food and Drug Administration (FDA) approval of gemcitabine injection, a solution form of the drug. The solution presentations include 200 mg, 1 gm and 2 gm with a concentration of 38 mg/ml. The oncology medication had U.S. sales of more than $750 million in 2010, led by Eli Lilly's Gemzar(®). Hospira expects to launch the product in early...
YORK, Pa., July 19, 2011 /PRNewswire/ -- Unilife Corporation ("Unilife" or the "Company") (NASDAQ: UNIS; ASX: UNS) today announced it has commenced the initial sale of the Unifill® ready-to-fill syringe to a U.S.-based global pharmaceutical company. The commencement of Unifill sales to this new customer, whose identity remains confidential at this time, follows the initial shipment of the device to Sanofi last week. Unilife continues to expand its customer pipeline as an increasing...
YORK, Pa., July 13, 2011 /PRNewswire/ -- Unilife Corporation ("Unilife" or the "Company") (NASDAQ: UNIS; ASX: UNS) today announced it has commenced the initial supply of validated product of the Unifill® syringe to Sanofi, as per the terms of the industrialization agreement between both parties. Since signing the Exclusive Agreement in July 2008, Sanofi has paid Unilife a total of approximately $40 million, comprising a $16 million (euro 10 million) fee in exchange for the exclusive...
LAKE FOREST, Ill., June 27, 2011 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), a leading global specialty pharmaceutical and medication delivery company, today announced that it will host a conference call to discuss its second-quarter 2011 results on Wednesday, July 27, 2011 at 8 a.m. Central time. The company will release its second-quarter results earlier that morning, before the U.S. stock market open and the conference call. A live webcast of the conference call and related material...
LAKE FOREST, Ill., May 20, 2011 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), a leading global specialty pharmaceutical and medication delivery company, today announced that the company will present at the Goldman Sachs 32nd Annual Global Healthcare Conference on Wednesday, June 8, 2011. The presentation is scheduled to begin at 8:40 a.m. Pacific time on Wednesday, June 8, 2011. It will be available to all interested parties through a live audiocast accessible via the investor relations...
LAKE FOREST, Ill., May 12, 2011 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), a leading global specialty pharmaceutical and medication delivery company, today announced that the company will present at the Sanford C. Bernstein Twenty-Seventh Annual Strategic Decisions Conference 2011 on Thursday, June 2, in New York. The presentation is scheduled to begin at 8:00 a.m. Eastern time on Thursday, June 2, 2011. It will be available to all interested parties through a live audiocast accessible via...
LAKE FOREST, Ill., May 10, 2011 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), a leading global specialty pharmaceutical and medication delivery company, today held its 2011 Annual Meeting of Shareholders in Washington, D.C. The agenda included votes on seven items as well as an update on the company's progress in 2010 and its position going forward. "2010 was a year marked with milestone achievements, but also scattered challenges," said F. Michael Ball, chief executive officer. "Through a...
YORK, Pa., April 27, 2011 /PRNewswire/ -- Unilife Corporation ("Unilife" or the "Company") (NASDAQ: UNIS; ASX: UNS) today announced that Mr. Jim Bosnjak OAM, Chairman of Unilife, issued a letter to shareholders as an update on the Company's business. Dear Shareholder, As Chairman of Unilife, it is my pleasure to inform you that our Company is rapidly expanding as a commercial manufacturer of innovative drug delivery devices to the pharmaceutical industry. Following the recent completion of...
